| Mr James Donald Lee, CRNA | |
|
2700 Holland Rd, Apex, NC 27502-9631 | |
| (919) 303-0339 | |
| (919) 303-4793 |
| Full Name | Mr James Donald Lee |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 39 Years |
| Location | 2700 Holland Rd, Apex, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114924818 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 080979 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke University Health System Inc | 2567372345 | 837 |
News Archive
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Lifeline Biotechnologies, Inc. today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
› Verified 5 days ago
| Entity Name | Duke University Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558392977 PECOS PAC ID: 2567372345 Enrollment ID: O20040625000811 |
News Archive
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Lifeline Biotechnologies, Inc. today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
› Verified 5 days ago
| Entity Name | Regional Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952486946 PECOS PAC ID: 3779681408 Enrollment ID: O20070604000698 |
News Archive
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Lifeline Biotechnologies, Inc. today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
› Verified 5 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1477609535 PECOS PAC ID: 1355254368 Enrollment ID: O20080418000444 |
News Archive
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Lifeline Biotechnologies, Inc. today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
› Verified 5 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Lifeline Biotechnologies, Inc. today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Donald Lee, CRNA 2700 Holland Rd, Apex, NC 27502-9631 Ph: (919) 303-0339 | Mr James Donald Lee, CRNA 2700 Holland Rd, Apex, NC 27502-9631 Ph: (919) 303-0339 |
News Archive
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Lifeline Biotechnologies, Inc. today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
› Verified 5 days ago
Detty Thomas Johnson, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8505 Newberry Grove Dr, Apex, NC 27539 Phone: 919-670-7547 | |
Mr. Robert L. Morris, MD Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 115 S Hughes St, Apex, NC 27502 Phone: 919-387-9747 Fax: 919-387-9747 | |
Mr. Bryan Aloysius Carrico, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 622 Eyam Hall Ln, Apex, NC 27502 Phone: 786-797-9911 Fax: 919-578-1511 | |
Ronald Kevin Mook, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 231 Constitution Ct, Apex, NC 27523 Phone: 919-454-3864 | |
Desirae V Flitcroft, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1972 Old Byre Way, Apex, NC 27502 Phone: 919-824-2427 Fax: 919-367-8001 |